SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors) such as empagliflozin, dapagliflozin, and canagliflozin represent excellent alternatives, providing cardiovascular and renal protection alongside modest weight loss (typically 2-4 kg)

Combined Synergistic Research Profile When investigated together, Glow Blend is commonly researched for complementary interaction with: Collagen-related and skin-integrity pathways Tissue-maintenance and regenerative signaling Recovery-focused physiological pathways Hair-, skin-, and dermal-maintenance pathways Soft-tissue and connective-tissue pathways Oxidative-stress and physiological-resilience pathways Healthy-aging and regenerative research models Research Interest in Glow Blend Commonly Includes: Skin texture and elasticity-related pathways Collagen-support and dermal-maintenance signaling Recovery-focused regenerative mechanisms Hair- and scalp-related pathways Tissue-maintenance and physiological-resilience research Healthy-aging and regenerative research investigations Because the blend combines peptides researched for different but complementary regenerative pathways, Glow Blend is commonly investigated as a multi-pathway regenerative and skin-integrity research formulation rather than a single-target compound

They both know and support the research and dedication of Pendulum CEO, Colleen Cutcliffe, Ph.D
Consultation with a Provider Get Qualified for Medication Begin Your Customized Program Convenient virtual visits While in-person visits are an important part of our successful program, we offer virtual appointments for when life gets busy, so youll never miss a visit